Загрузка...
Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
Inflammatory bowel disease (IBD) is a chronic and heterogeneous intestinal inflammatory disorder. The medical management of IBD aims for long-lasting disease remission to prevent complications and disease progression. Early introduction of immunosuppression forms the mainstay of medical IBD manageme...
Сохранить в:
| Опубликовано в: : | World J Gastroenterol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558438/ https://ncbi.nlm.nih.gov/pubmed/31210708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i21.2539 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|